BDBM263530 3-(4-{5-amino-4-[5- (morpholine-4-carbonyl)-1h- indole-2-carbonyl]-pyrazol-1- yl}-3-methyl-phenoxy)- benzonitrile::US9556150, i-18
SMILES: Cc1cc(Oc2cccc(c2)C#N)ccc1-n1ncc(C(=O)c2cc3cc(ccc3[nH]2)C(=O)N2CCOCC2)c1N
InChI Key: InChIKey=DXKVGAPNDQXAPY-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM263530 (3-(4-{5-amino-4-[5- (morpholine-4-carbonyl)-1h- in...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.20 | n/a | n/a | n/a | n/a | 7.15 | n/a |
Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. US Patent | Assay Description This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (Förster/Fluorescenc... | US Patent US9556150 (2017) BindingDB Entry DOI: 10.7270/Q2571F1S | |||||||||||
More data for this Ligand-Target Pair |